Related references
Note: Only part of the references are listed.PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma
Marlon Husstegge et al.
ONCOIMMUNOLOGY (2021)
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley et al.
BRITISH JOURNAL OF CANCER (2020)
Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
Zhiying Qin et al.
FRONTIERS IN PHARMACOLOGY (2020)
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Antonietta Rosella Farina et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells
Limin Wang et al.
CANCER SCIENCE (2019)
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar et al.
CLINICAL CANCER RESEARCH (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
Steve Z. Martin et al.
BMC CANCER (2019)
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma
Rasmus Soennichsen et al.
CLINICAL COLORECTAL CANCER (2018)
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens
Jeff DeFalco et al.
CLINICAL IMMUNOLOGY (2018)
Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses
Simone L. Park et al.
NATURE IMMUNOLOGY (2018)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
Is genome-guided cancer treatment hyped? New tailored therapies can work wonders, but the pace of development is slow
Jocelyn Kaiser
SCIENCE (2018)
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
Edwin R. Parra et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
S. N. Gettinger et al.
NATURE COMMUNICATIONS (2018)
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Dmitrij Ostroumov et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K. Finnberg et al.
ONCOTARGET (2017)
Multiparametric immune profiling in HPV-oral squamous cell cancer
Zipei Feng et al.
JCI INSIGHT (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Ex Vivo Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy
Ellie Karekla et al.
CANCER RESEARCH (2017)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
George Plitas et al.
IMMUNITY (2016)
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation
Qian Gong et al.
MABS (2016)
Organotypic slice cultures of human gastric and esophagogastric junction cancer
Justus Koerfer et al.
CANCER MEDICINE (2016)
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response
John Reiser et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors
Sabine H. van Rijt et al.
ACS NANO (2015)
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10
Huimin Tao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
The prognostic influence of tumor infiltrating Foxp3+CD4+, CD4+ and CD8+ T cells in resected non-small cell lung cancer
Jurgita Jackute et al.
JOURNAL OF INFLAMMATION-LONDON (2015)
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
Zipei Feng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells
Katharina Leithner et al.
BMC CANCER (2014)
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M. M. Gerlach et al.
BRITISH JOURNAL OF CANCER (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PD-1 is a novel regulator of human B-cell activation
Marie-Laure Thibult et al.
INTERNATIONAL IMMUNOLOGY (2013)
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
Felicitas Merz et al.
NEURO-ONCOLOGY (2013)
PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
John Dulos et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Pauline Andreu et al.
CANCER CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy
Qiao Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Share Paper
